Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PDE4A anticorps

PDE4A Reactivité: Humain, Souris, Rat, Élan WB, IHC, ELISA, IF, IP, ICC, CM Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN2750880
  • Antigène Voir toutes PDE4A Anticorps
    PDE4A (phosphodiesterase 4A, CAMP-Specific (PDE4A))
    Reactivité
    • 49
    • 35
    • 27
    • 8
    • 5
    • 5
    • 5
    • 3
    • 2
    Humain, Souris, Rat, Élan
    Hôte
    • 45
    • 4
    Lapin
    Clonalité
    • 47
    • 2
    Polyclonal
    Conjugué
    • 16
    • 5
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp PDE4A est non-conjugé
    Application
    • 48
    • 20
    • 13
    • 10
    • 9
    • 6
    • 6
    • 5
    • 4
    • 3
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF), Immunoprecipitation (IP), Immunocytochemistry (ICC), Confocal Microscopy (CM)
    Purification
    Affinity Purified
    Immunogène
    Synthetic cyclic peptide common to all PDE4A proteins.
    Isotype
    IgG
    Top Product
    Discover our top product PDE4A Anticorps primaire
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.65-1.00 μg/μL
  • Avila, Barker, Zhang, McClain, Barve, Gobejishvili: "Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis." dans: The Journal of pathology, Vol. 240, Issue 1, pp. 96-107, (2017) (PubMed).

    Massimi, Cardarelli, Galli, Giardi, Ragusa, Panera, Cinque, Cifone, Biagioni, Giorgi: "Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival." dans: Journal of cellular biochemistry, Vol. 118, Issue 6, pp. 1401-1411, (2016) (PubMed).

    Petersen, Kristensen, Jeppesen, Grøndahl, Wissing, Macklon, Andersen: "Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary." dans: Molecular and cellular endocrinology, Vol. 403, pp. 10-20, (2015) (PubMed).

    Kedia, Ückert, Oelke, Sonnenberg, Sohn, Kuczyk, Hedlund: "Expression and distribution of phosphodiesterase isoenzymes in the human male urethra." dans: Urology, Vol. 85, Issue 4, pp. 964.e1-6, (2015) (PubMed).

    Yougbaré, Boire, Roy, Lugnier, Rouseau: "NCS 613 exhibits anti-inflammatory effects on PBMCs from lupus patients by inhibiting p38 MAPK and NF-κB signalling pathways while reducing proinflammatory cytokine production." dans: Canadian journal of physiology and pharmacology, Vol. 91, Issue 5, pp. 353-61, (2014) (PubMed).

    Guo, Lin, Zhao, Zhang, Wei, Wang, Wang: "Etazolate abrogates the lipopolysaccharide (LPS)-induced downregulation of the cAMP/pCREB/BDNF signaling, neuroinflammatory response and depressive-like behavior in mice." dans: Neuroscience, Vol. 263, pp. 1-14, (2014) (PubMed).

    Zhai, Chang, Wei, Liu, Leblais, Fischmeister, Ji: "Phosphodiesterase types 3 and 4 regulate the phasic contraction of neonatal rat bladder smooth myocytes via distinct mechanisms." dans: Cellular signalling, Vol. 26, Issue 5, pp. 1001-10, (2014) (PubMed).

    Vang, Housley, Dong, Basole, Ben-Sasson, Kream, Epstein, Clark, Brocke: "Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac." dans: The Biochemical journal, Vol. 456, Issue 3, pp. 463-73, (2013) (PubMed).

    Ückert, Waldkirch, Sonnenberg, Sandner, Kuczyk, Hedlund: "Expression and distribution of phosphodiesterase isoenzymes in the human seminal vesicles." dans: The journal of sexual medicine, Vol. 8, Issue 11, pp. 3058-65, (2012) (PubMed).

    Waldkirch, Ückert, Sigl, Satzger, Geismar, Langnäse, Richter, Sohn, Kuczyk, Hedlund: "Expression of cyclic AMP-dependent protein kinase isoforms in human cavernous arteries: functional significance and relation to phosphodiesterase type 4." dans: The journal of sexual medicine, Vol. 7, Issue 6, pp. 2104-2111, (2011) (PubMed).

    Abusnina, Alhosin, Keravis, Muller, Fuhrmann, Bronner, Lugnier: "Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis." dans: Cellular signalling, Vol. 23, Issue 1, pp. 152-60, (2011) (PubMed).

    Yougbare, Morin, Senouvo, Sirois, Albadine, Lugnier, Rousseau: "NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues." dans: American journal of physiology. Lung cellular and molecular physiology, Vol. 301, Issue 4, pp. L441-50, (2011) (PubMed).

    Vedin, Eriksson, Berghard: "Organization of the chemosensory neuroepithelium of the vomeronasal organ of the Scandinavian moose Alces alces." dans: Brain research, Vol. 1306, pp. 53-61, (2010) (PubMed).

    Fatemi, Folsom, Reutiman, Braun, Lavergne: "Levels of phosphodiesterase 4A and 4B are altered by chronic treatment with psychotropic medications in rat frontal cortex." dans: Synapse (New York, N.Y.), Vol. 64, Issue 7, pp. 550-5, (2010) (PubMed).

    Waldkirch, Uckert, Sigl, Langnaese, Richter, Stief, Kuczyk, Hedlund: "Expression of cAMP-dependent protein kinase isoforms in the human prostate: functional significance and relation to PDE4." dans: Urology, Vol. 76, Issue 2, pp. 515.e8-14, (2010) (PubMed).

    Fatemi, Reutiman, Folsom, Lee: "Phosphodiesterase-4A expression is reduced in cerebella of patients with bipolar disorder." dans: Psychiatric genetics, Vol. 18, Issue 6, pp. 282-8, (2009) (PubMed).

    Hörnberg, Gussing, Berghard, Bohm: "Retinoic acid selectively inhibits death of basal vomeronasal neurons during late stage of neural circuit formation." dans: Journal of neurochemistry, Vol. 110, Issue 4, pp. 1263-75, (2009) (PubMed).

    Liu, Fraser, Koos: "Grueneberg ganglion olfactory subsystem employs a cGMP signaling pathway." dans: The Journal of comparative neurology, Vol. 516, Issue 1, pp. 36-48, (2009) (PubMed).

    Zhang, Huang, Masood, Stolinski, Li, Zhang, Dlaboga, Jin, Conti, ODonnell: "Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B)." dans: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Vol. 33, Issue 7, pp. 1611-23, (2008) (PubMed).

    Braun, Reutiman, Lee, Folsom, Fatemi: "Expression of phosphodiesterase 4 is altered in the brains of subjects with autism." dans: Neuroreport, Vol. 18, Issue 17, pp. 1841-4, (2008) (PubMed).

  • Antigène
    PDE4A (phosphodiesterase 4A, CAMP-Specific (PDE4A))
    Autre désignation
    PDE4A (PDE4A Produits)
    Synonymes
    anticorps pde4, anticorps dpde2, anticorps pde46, anticorps PDE4A, anticorps Pde4a, anticorps D9Ertd60e, anticorps Dpde2, anticorps DPDE2, anticorps PDE4, anticorps PDE46, anticorps PHOSA, anticorps phosphodiesterase 4A S homeolog, anticorps phosphodiesterase 4A, cAMP-specific, anticorps phosphodiesterase 4A, anticorps phosphodiesterase 4A, cAMP-specific (phosphodiesterase E2 dunce homolog, Drosophila), anticorps cAMP-specific 3',5'-cyclic phosphodiesterase 4A, anticorps phosphodiesterase 4A, cAMP specific, anticorps phosphodiesterase 4C, anticorps pde4a.S, anticorps pde4a, anticorps PDE4A, anticorps LOC100009247, anticorps Pde4a, anticorps PDE4C
    UniProt
    P27815
    Pathways
    cAMP Metabolic Process
Vous êtes ici:
Support technique